DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer (DOSAGE)
DOSAGE Study: a Multicenter Randomized Phase III Trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older Patients
Sponsor: Dutch Colorectal Cancer Group
This PHASE3 trial investigates Candidates for Palliative Chemotherapy and Colorectal Cancer and is currently actively recruiting participants. Dutch Colorectal Cancer Group leads this study, which shows 6 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
Nov 2024 — Sep 2025 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Not Yet Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Not Yet Recruiting PHASE3
▶ Show 1 earlier version
-
Mar 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Dutch Colorectal Cancer Group
- Leiden University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .